This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Durvalumab

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Durvalumab Means in Everyday Medical Language

Durvalumab is a medicine used to treat certain types of cancer. It belongs to a group of drugs called immune checkpoint inhibitors. These drugs help the immune system find and attack cancer cells more effectively. Durvalumab works by blocking a protein called PD-L1, which some cancer cells use to hide from the immune system. By blocking PD-L1, durvalumab helps the immune system recognize and kill cancer cells.

Why Durvalumab Can Matter in Cancer Care

Durvalumab is important because it offers a treatment option that uses the body's own defenses to fight cancer. It is approved for several cancers, including bladder cancer that has spread into muscle, certain types of lung cancer, biliary tract cancers (such as bile duct and gallbladder cancer), endometrial cancer, and liver cancer that cannot be removed by surgery. It can be used alone or with chemotherapy or other drugs depending on the type and stage of cancer. For some patients, durvalumab may help control the cancer or slow its growth after other treatments like chemotherapy and radiation.

What Patients Might See or Hear About Durvalumab

Patients may hear the name durvalumab or its brand name Imfinzi during discussions about treatment options. It might appear in medical reports, treatment plans, or clinical trial information. Sometimes it is used after chemotherapy and radiation, or combined with other drugs as part of a first treatment. Patients might also hear about side effects or the need for regular monitoring while on durvalumab. Because it is an immunotherapy, side effects can include immune-related reactions that should be reported to the care team promptly.

Where Durvalumab Might Appear in Care and Reports

Durvalumab may be mentioned in your medical records, treatment plans, or during visits with your healthcare team. It can also appear in clinical trial listings if you are considering research studies. The drug is often part of a combined treatment approach, so it may be listed alongside chemotherapy drugs or other immunotherapies. Understanding where and how durvalumab fits into your care can help you ask informed questions and understand your treatment goals.

What Durvalumab Does Not Automatically Mean

Hearing about durvalumab does not mean the cancer is untreatable or that it will definitely work for every patient. It is one option among many, and its use depends on the specific type and stage of cancer, as well as other health factors. Also, durvalumab is not a cure for all cancers but may help control the disease or improve outcomes in some cases. It is important not to assume outcomes without discussing your individual situation with your care team.

Common Questions to Ask Your Care Team

If durvalumab is part of your treatment, you might ask how it works for your specific cancer, what side effects to watch for, and how it will be given (alone or with other drugs). You can also ask about how long treatment might last, how your response will be monitored, and what to do if side effects occur. Understanding these details can help you feel more confident and prepared during treatment.

How to Read the Term in Context

Durvalumab may appear under different names like Imfinzi, so it helps to compare information carefully. When you see the term, consider the full context—such as the type of cancer, treatment stage, and whether it is combined with other medicines. This helps avoid confusion and ensures you understand how it applies to your care.

Important Safety and Context Information

This information about durvalumab is educational and does not replace medical advice. The drug may cause side effects and is not suitable for everyone. Always talk with your healthcare provider about your specific condition and treatment options before starting or changing any therapy.

Next Steps for Patients and Caregivers

If you see durvalumab mentioned in your care or reports, the best next step is to ask your healthcare team what it means for your treatment. They can explain how it fits into your plan, what to expect, and how to manage any side effects. Staying informed and involved in your care helps you make the best decisions for your health.

Sources

Public source information used for this glossary entry includes: